Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 10,568
- 试验地点
- 1
- 主要终点
- Clinical outcomes (ischemic and bleeding) incidence and time to these clinical outcomes
研究概览
简要总结
The aim of this international study is to describe the short- and long-term (i.e. up to 2 years following the index event) antithrombotic management patterns (AMPs) in patients hospitalized for acute coronary syndromes (ST segment elevation myocardial infarction (STEMI), Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS)), and to document the impact of AMPs in clinical outcomes, economic variables and quality of life in a 'real-life' setting and to compare these between sites, countries and regions.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of myocardial infarction or unstable angina
- •Hospitalized for the first time within 24 hours of onset of symptoms
排除标准
- •Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances)
- •Current participation in a clinical trial.
结局指标
主要结局
Clinical outcomes (ischemic and bleeding) incidence and time to these clinical outcomes
时间窗: Longitudinal during 2 years after index event (phone calls to the patients at 6 weeks and each 3 months after index event)
次要结局
- Antithrombotic treatments(Longitudinal during 2 years after index event (phone calls to the patients at 6 weeks and each 3 months after index event))
- Use of health care resources(Longitudinal during 2 years after index event (phone calls to the patients at 6 weeks and each 3 months after index event))
- Quality of life(At index event (baseline) and then at 6 weeks and each 3 months after index event)
